Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066690
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-02
First Post:
2003-08-06
Brief Title:
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Organization Data
Organization:
ETOP IBCSG Partners Foundation
Class:
NETWORK
Study ID:
IBCSG 24-02 BIG 2-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ETOP IBCSG Partners Foundation
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Breast International Group | OTHER |
| Cancer and Leukemia Group B | NETWORK |
| National Cancer Institute NCI | NIH |
| NSABP Foundation Inc | NETWORK |
| NCIC Clinical Trials Group | NETWORK |
| North Central Cancer Treatment Group | NETWORK |
| SWOG Cancer Research Network | NETWORK |